Elanco Animal Health Incorporated (ELAN) Financial Statements (2024 and earlier)

Company Profile

Business Address 2500 INNOVATION WAY
GREENFIELD, IN 46140
State of Incorp.
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in millions)

9/30/2023
MRQ
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments345638495334475
Cash and cash equivalents345638495334475
Restricted cash and investments   1111203
Receivables1,0021,0281,077890709
Inventory, net of allowances, customer advances and progress billings1,5381,3731,5781,0511,004
Inventory1,5381,3731,5781,0511,004
Other undisclosed current assets39423725687114
Total current assets:3,2793,2763,4172,3732,505
Noncurrent Assets
Property, plant and equipment9991,0611,316955922
Intangible assets, net (including goodwill)10,83511,75912,6125,4725,411
Goodwill5,9936,1726,2252,9902,958
Intangible assets, net (excluding goodwill)4,8425,5876,3872,4832,453
Other noncurrent assets378387348185103
Other undisclosed noncurrent assets     15
Total noncurrent assets:12,21213,20714,2766,6136,452
TOTAL ASSETS:15,49116,48317,6938,9868,957
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities536603645322304
Employee-related liabilities18514410099
Accounts payable390418501223205
Accrued liabilities 146    
Deferred revenue324316295211
Debt3882945552529
Due to related parties  516 
Contract with customer, liability170
Other liabilities454430577244199
Other undisclosed current liabilities     269
Total current liabilities:1,7021,6432,076819971
Noncurrent Liabilities
Long-term debt and lease obligation5,4486,0255,5722,3312,443
Long-term debt, excluding current maturities5,4486,0255,5722,3312,443
Liabilities, other than long-term debt1,0521,2771,568290231
Deferred income tax liabilities662745900101
Liability, pension and other postretirement and postemployment benefits 16127134683109
Other liabilities229261322107122
Other undisclosed noncurrent liabilities     115
Total noncurrent liabilities:6,5007,3027,1412,6202,789
Total liabilities:8,2028,9459,2173,4393,759
Equity
Equity, attributable to parent7,2897,5388,4765,5475,198
Additional paid in capital8,7388,6968,6505,6365,403
Accumulated other comprehensive income (loss)(392)(209)303(174)(222)
Retained earnings (accumulated deficit)(1,057)(949)(477)8416
Total equity:7,2897,5388,4765,5475,198
TOTAL LIABILITIES AND EQUITY:15,49116,48317,6938,9868,957

Income Statement (P&L) ($ in millions)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Revenues4,4114,7653,2733,0713,067
Cost of revenue(2,186)(2,375)(1,667)(1,577)(1,645)
Cost of goods and services sold(1,913)(2,134)(1,667)(1,470)(1,574)
Gross profit:2,2252,3901,6071,4941,422
Operating expenses(2,297)(2,957)(2,307)(1,416)(1,308)
Operating income (loss):(72)(567)(701)78114
Nonoperating income (expense)(32)(5)178(27)(41)
Interest and debt expense(241)(236)(150)(79)(30)
Income (loss) from continuing operations before equity method investments, income taxes:(345)(808)(672)(28)43
Other undisclosed income from continuing operations before income taxes273241 10671
Income (loss) from continuing operations before income taxes:(72)(567)(672)78114
Income tax expense (benefit)(6)95112(10)(28)
Income (loss) from continuing operations:(78)(472)(560)6887
Income (loss) before gain (loss) on sale of properties:(472)(560)6887
Net income (loss) available to common stockholders, diluted:(78)(472)(560)6887

Comprehensive Income ($ in millions)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Net income (loss):(78)(472)(560)6887
Other comprehensive income (loss)(183)(512)47749(22)
Comprehensive income (loss):(261)(984)(83)11665
Other undisclosed comprehensive loss, net of tax, attributable to parent     
Comprehensive income (loss), net of tax, attributable to parent:(261)(984)(83)11665

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: